These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33551734)

  • 1. The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer's Disease.
    Fan DY; Sun HL; Sun PY; Jian JM; Li WW; Shen YY; Zeng F; Wang YJ; Bu XL
    Front Neurosci; 2020; 14():625844. PubMed ID: 33551734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Dubini A; Torre S; Colombo E; Doretti A; Gentile F; Manini A; Milone I; Brusati A; Peverelli S; Santangelo S; Spinelli EG; Torresani E; Gentilini D; Messina S; Morelli C; Poletti B; Agosta F; Ratti A; Filippi M; Silani V; Ticozzi N
    Eur J Neurol; 2024 Jun; ():e16374. PubMed ID: 38853763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid pathology mediates the associations between plasma fibrinogen and cognition in non-demented adults.
    Ma LY; Song JH; Gao PY; Ou YN; Fu Y; Huang LY; Wang ZT; Zhang DD; Cui RP; Mi YC; Tan L;
    J Neurochem; 2024 Mar; ():. PubMed ID: 38533619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease.
    Bu XL; Sun PY; Fan DY; Wang J; Sun HL; Cheng Y; Zeng GH; Chen DW; Li HY; Yi X; Shen YY; Miles LA; Maruff P; Gu BJ; Fowler CJ; Masters CL; Wang YJ
    Sci Adv; 2022 Apr; 8(13):eabm5667. PubMed ID: 35363517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
    Van Hulle C; Ince S; Okonkwo OC; Bendlin BB; Johnson SC; Carlsson CM; Asthana S; Love S; Blennow K; Zetterberg H; Scott Miners J
    Transl Psychiatry; 2024 Jan; 14(1):3. PubMed ID: 38182581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease.
    Pradeepkiran JA; Baig J; Islam MA; Kshirsagar S; Reddy PH
    Aging Dis; 2024 Apr; ():. PubMed ID: 38739937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
    Miners J; van Hulle C; Ince S; Jonaitis E; Okonkwo OC; Bendlin B; Johnson S; Carlsson C; Asthana S; Love S; Blennow K; Zetterberg H
    Res Sq; 2023 Apr; ():. PubMed ID: 37131622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid irisin correlates with amyloid-β, BDNF, and cognition in Alzheimer's disease.
    Lourenco MV; Ribeiro FC; Sudo FK; Drummond C; Assunção N; Vanderborght B; Tovar-Moll F; Mattos P; De Felice FG; Ferreira ST
    Alzheimers Dement (Amst); 2020; 12(1):e12034. PubMed ID: 32582833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Alzheimer's disease biomarkers and postoperative delirium or cognitive dysfunction: A meta-analysis and trial sequential analysis of prospective clinical trials.
    Geng J; Zhang Y; Chen H; Shi H; Wu Z; Chen J; Luo F
    Eur J Anaesthesiol; 2024 Mar; 41(3):234-244. PubMed ID: 38038408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF Aβ40 Levels Do Not Correlate with the Clinical Manifestations of Alzheimer's Disease.
    Garcia Castro J; Méndez Del Sol H; Rodríguez Fraga O; Hernández Barral M; Serrano López S; Frank García A; Martín Montes Á
    Neurodegener Dis; 2022; 22(3-4):151-158. PubMed ID: 37231965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal motor cortical plasticity as a useful neurophysiological biomarker for Alzheimer's disease pathology.
    Murakami T; Abe M; Tiksnadi A; Nemoto A; Futamura M; Yamakuni R; Kubo H; Kobayashi N; Ito H; Hanajima R; Hashimoto Y; Ugawa Y
    Clin Neurophysiol; 2024 Feb; 158():170-179. PubMed ID: 38219406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys.
    Kavanagh K; Day SM; Pait MC; Mortiz WR; Newgard CB; Ilkayeva O; Mcclain DA; Macauley SL
    Front Neurosci; 2019; 13():843. PubMed ID: 31555072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF dynamics of orexin and β-amyloid
    Lozano-Tovar S; Nuccetelli M; Placidi F; Izzi F; Sancesario G; Bernardini S; Biagio Mercuri N; Liguori C
    Neurosci Lett; 2024 Jul; ():137914. PubMed ID: 39032802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease.
    Guo Q; Ping L; Dammer EB; Yin L; Xu K; Shantaraman A; Fox EJ; Golde TE; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Res Sq; 2024 Feb; ():. PubMed ID: 38464223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
    Del Campo Milan M; Zuroff L; Jimenez CR; Scheltens P; Teunissen CE
    Alzheimers Dement (Amst); 2015 Mar; 1(1):75-80. PubMed ID: 27239494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global Alzheimer's Association round robin study on plasma amyloid β methods.
    Pannee J; Shaw LM; Korecka M; Waligorska T; Teunissen CE; Stoops E; Vanderstichele HMJ; Mauroo K; Verberk IMW; Keshavan A; Pesini P; Sarasa L; Pascual-Lucas M; Fandos N; Allué JA; Portelius E; Andreasson U; Yoda R; Nakamura A; Kaneko N; Yang SY; Liu HC; Palme S; Bittner T; Mawuenyega KG; Ovod V; Bollinger J; Bateman RJ; Li Y; Dage JL; Stomrud E; Hansson O; Schott JM; Blennow K; Zetterberg H
    Alzheimers Dement (Amst); 2021; 13(1):e12242. PubMed ID: 34692980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma amyloid β levels in Alzheimer's disease and cognitively normal controls in Syrian population.
    Manafikhi R; Haik MB; Lahdo R; AlQuobaili F
    Med J Islam Repub Iran; 2021; 35():19. PubMed ID: 33996670
    [No Abstract]   [Full Text] [Related]  

  • 18. Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease.
    Thomas P; Leclerc M; Evitts K; Brown C; Miller W; Hanson AJ; Banks WA; Gibbons L; Domoto-Reilly K; Jayadev S; Li G; Peskind E; Young JE; ; Calon F; Rhea EM
    Alzheimers Dement (Amst); 2024; 16(2):e12603. PubMed ID: 38800123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.
    Kamer AR; Pushalkar S; Gulivindala D; Butler T; Li Y; Annam KRC; Glodzik L; Ballman KV; Corby PM; Blennow K; Zetterberg H; Saxena D; de Leon MJ
    Alzheimers Dement (Amst); 2021; 13(1):e12172. PubMed ID: 33869725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally distinct pericyte subsets differently regulate amyloid-β deposition in patients with Alzheimer's disease.
    Bohannon DG; Long D; Okhravi HR; Lee SC; De Jesus CL; Neubert TA; Rostagno AA; Ghiso JA; Kim WK
    Brain Pathol; 2024 Jun; ():e13282. PubMed ID: 38932696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.